Lotezar Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation, and anterior uveitis. Loteprednol etabonate is a synthetic corticosteroid with potent anti-inflammatory properties that exert their effect by inhibiting the release of inflammatory mediators and suppressing leukocyte infiltration at the site of inflammation. This medication is formulated for topical ocular use, providing targeted relief while minimizing systemic absorption and associated side effects. Lotezar Eye Drop is typically administered as one or two drops into the affected eye(s) four times daily or as directed by a healthcare professional. It is essential to use this medication under strict medical supervision, as prolonged use may increase the risk of elevated intraocular pressure, cataract formation, or secondary ocular infections. Patients should be monitored regularly for intraocular pressure changes and any signs of adverse reactions. This product is contraindicated in viral, fungal, or mycobacterial ocular infections. Lotezar Eye Drop offers an effective therapeutic option for managing ocular inflammation, improving patient comfort and visual outcomes when used appropriately.